Back

Photobiomodulation attenuates myocardial fibrosis and diastolic dysfunction in a mouse model of heart-failure with preserved ejection fraction

27 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Myocardial remodelling (3) Heart Failure ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Dean Nachman

Hadassah - Hebrew University Medical Center Jerusalem, Jerusalem (Israel)

7 More presentations in this session

Presentation thumbnail
Treatment with empagliflozin improves cardiac function in infarcted animals associated with increased baroreflex sensitivity
Mr B. Da Silva (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Differential impact of comorbidities and sex on pathophysiological pathways leading to heart failure with preserved ejection fraction
Doctor E. Lara-Pezzi (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Increased pro-remodeling and pro-thrombotic responses in the left compared to the right atrial appendage: role of low-grade inflammation and the AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway
Doctor W. Fakih (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Concurrent left ventricular pressure-loading improves right ventricular function, remodeling, and molecular signaling in response to pulmonary artery banding
Mr X. Lee (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Cardiac-specific deletion of myosin phosphatase targeting subunit 2 alleviates cardiac fibrosis in mineralocorticoid receptor-related hypertension
Ms Z. Ye (Tsu, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial remodelling (3)

The Event

Event poster

ESC Congress 2023

27 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Photobiomodulation mitigates diastolic dysfunction, reduces perivascular fibrosis and inflammation, and enhances mitochondrial metabolism and angiogenesis in a mouse model of HFpEF
thumbnail
Congress Presentation
ACEI plus GLP1-RA or SGLT2i, as well as ARNI, exerted distinct protective effects against diabetic nephropathy and heart failure with preserved ejection fraction in eNOS-/- dbdb mice.
thumbnail
Congress Presentation
Gradual hypertensive response in aortic alterations and myocardial inflammatory activation in progressing HFpEF in mice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources